Al-Shali K., Wang J., Fellows F. et al. Successful pregnancy outcome in a patient with severe chylomicronaemia due to compound heterozygosity for mutant lipoprotein lipase. Clin Biochem2002;35:125-30.
2.
Mingrone G., Henriksen FL, Greco AV et al. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes1999;48: 1258-63.
3.
Holzl B., Iglseder B., Sandhofer A. et al. Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency. Diabetologia2002; 45:377-84.
4.
Thompson GRA Handbook of hyperlipidaemiaCurrent Science1989: 101-11.
5.
Rouis M., Dugi KA, Previato L. et al. Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronaemia syndrome. Arterioscler Thromb Vasc Biol1997;17:1400-06.
6.
Benlian P., De Gennes JL, Foubert L. et al. Premature atherosclerosis in patients with familial chylomicronaemia caused by mutations in the lipoprotein lipase gene. N Engl J Med1996;335:848-54.
7.
Bircher J, Benhamon JP, McIntyre N, Rizzetto M, Rodés J (eds.). In: Oxford Textbook of Clinical Hepatology. 2nd Edition. Oxford Medical Publications, 1999.